SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc. today announced that it has submitted the FilmArray Blood Culture Identification (BCID) Panel to the U.S. Food and Drug Administration (FDA) ...
Just a month out from being bought by French giant bioMérieux, BioFire Diagnostics took its FilmArray diagnostic system's new gastrointestinal option to the FDA for clearance, which the newly united ...
> bioMérieux's BioFire Diagnostics division got an FDA nod and European approval for an updated version of its FilmArray PCR molecular diagnostic system, FilmArray 2.0.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results